T&F Informa plc, a leading provider of high value, specialist information to the academic, professional and commercial markets, announced today the appointment of Pamela J. Kirby PhD as a Non-Executive Director of the company with effect from 1 September 2004.

Dr Kirby (50) is currently a Non-Executive Director of Smith and Nephew plc and Oscient Pharmaceuticals Corporation. She was previously CEO of US based Quintiles Transnational Corporation, a provider of product development and commercial services to the pharmaceutical and biotechnology industries. Prior to joining Quintiles, Dr Kirby held various senior positions in the pharmaceutical industry at Astra AB (now AstraZeneca PLC), British Biotech plc (now Vernalis plc) and F. Hoffmann-La Roche Limited. Dr Kirby has a PhD in Clinical Pharmacology from the University of London.

Commenting on the appointment David Smith, Chairman of T&F Informa said:

"Pam brings a great deal of business and corporate experience to the team, especially in the high growth life sciences and pharmaceutical markets where the enlarged group has significant positions and products. She also has strong experience in international markets."

For further information, please contact:

T&F Informa plc	020 7017 5000
David Smith, Chairman
Financial Dynamics	020 7831 3113
Tim Spratt / Charles Palmer